Dr. Canamasas has served as a member of our board of directors since April 2022. She is the Chief Executive Officer of AtG Therapeutics, a preclinical stage biotech focused on stopping cancer metabolic adaptation. She was formerly the Head of Oncology EMEA and Commercial Lead for Oncology in the Region for Bayer Consumer Care AG, Switzerland, a subsidiary of Bayer AG. During her 20 plus years at Bayer, Dr. Canamasas held various oncology leadership positions with expertise focused on global commercialization, strategic life-cycle development and corporate strategy, including roles as Vice President of Global Marketing Oncology and Managing Director of Bayer Limited. Dr. Canamasas is also the Organizational Development Director for the Ambassador Program at the Healthcare Businesswomen’s Association (HBA). Dr. Canamasas holds an M.S. in Biology with distinction from the Universitat de Barcelona and a Ph.D. in Cancer Genetics from the University of Mainz.